Jazz Pharmaceuticals plc
JAZZ· Nasdaq
Released May 8, 2018, after the close
10-Q filed May 8, 2018, 38 days after period end · 0001232524-18-000094
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $444.61M | $376.05M | $336.01M | $309.30M |
| Net Income | $45.99M | $86.51M | $75.81M | $70.70M |
| EPS Diluted | $0.75 |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| $1.41 |
| $1.21 |
| $1.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.